Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Penumbra, Inc. Common Stock
(NY:
PEN
)
296.37
-23.11 (-7.23%)
Streaming Delayed Price
Updated: 1:36 PM EST, Jan 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Penumbra, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
What Analysts Are Saying About Penumbra Stock
↗
March 14, 2025
Via
Benzinga
ResMed Among Top Stocks For Recent And Long-Term Profit Growth
↗
March 10, 2025
A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue?
Via
Investor's Business Daily
3 Mid-Cap Stocks in Hot Water
February 28, 2025
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...
Via
StockStory
Merit Medical Systems (MMSI) Q4 Earnings Report Preview: What To Look For
February 24, 2025
Medical device company Merit Medical Systems (NASDAQ:MMSI) will be announcing earnings results tomorrow after market close. Here’s what to look for.
Via
StockStory
Artivion (AORT) Q4 Earnings: What To Expect
February 23, 2025
Medical device company Artivion (NYSE:AORT) will be reporting results tomorrow after the bell. Here’s what you need to know.
Via
StockStory
10 Analysts Assess Penumbra: What You Need To Know
↗
January 21, 2025
Via
Benzinga
Peering Into Penumbra's Recent Short Interest
↗
January 20, 2025
Via
Benzinga
(PEN) - Analyzing Penumbra's Short Interest
↗
December 24, 2024
Via
Benzinga
Stroke Device Maker Penumbra Stock Surges On Earnings Beat, Analysts Boost Price Forecasts After Upbeat 2025 Outlook
↗
February 19, 2025
Penumbra stock climbs after Q4 earnings surpass expectations, with sales up 10.8% Y/Y. Analysts raise price targets as the company projects strong 2025 growth.
Via
Benzinga
Topics
Earnings
Why Penumbra (PEN) Stock Is Trading Up Today
February 19, 2025
Shares of medical device company Penumbra (NYSE:PEN) jumped 13.6% in the afternoon session after the company reported impressive fourth-quarter 2024 results, which blew past analysts' constant currency...
Via
StockStory
Garmin Posts Better-Than-Expected Results, Joins SolarEdge Technologies, Compass, Appian And Other Big Stocks Moving Higher On Wednesday
↗
February 19, 2025
Via
Benzinga
Price Over Earnings Overview: Penumbra
↗
December 11, 2024
Via
Benzinga
12 Analysts Assess Penumbra: What You Need To Know
↗
December 11, 2024
Via
Benzinga
(PEN) - Analyzing Penumbra's Short Interest
↗
November 29, 2024
Via
Benzinga
Profit Machine Penumbra Surges On Solid Fourth-Quarter Beat, But Guidance Lags
↗
February 19, 2025
The company easily beat fourth-quarter expectations. But there was one drawback in its report.
Via
Investor's Business Daily
Penumbra’s (NYSE:PEN) Q4 Sales Beat Estimates
February 18, 2025
Medical device company Penumbra (NYSE:PEN) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 10.8% year on year to $315.5 million. On the other hand, the company’s...
Via
StockStory
Topics
Earnings
Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings
February 17, 2025
Medical device company Penumbra (NYSE:PEN) will be reporting earnings tomorrow afternoon. Here’s what you need to know.
Via
StockStory
Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack
February 14, 2025
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including Artivion (NYSE:AORT) and its peers.
Via
StockStory
Breaking Down Penumbra: 11 Analysts Share Their Views
↗
November 20, 2024
Via
Benzinga
Earnings Scheduled For February 18, 2025
↗
February 18, 2025
Via
Benzinga
Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
February 14, 2025
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including...
Via
StockStory
Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3
February 13, 2025
Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Penumbra (NYSE:PEN) and its peers.
Via
StockStory
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Merit Medical Systems (NASDAQ:MMSI) Vs The Rest
February 13, 2025
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including Merit Medical Systems...
Via
StockStory
This MongoDB Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
January 21, 2025
Via
Benzinga
Inspire Medical's Sleep Innovations Driving Big Gains
↗
January 08, 2025
Inspire Medical, which makes innovative apnea relief devices, hit a key performance benchmark as its Relative Strength Rating jumped to 81.
Via
Investor's Business Daily
UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday
↗
January 07, 2025
Via
Benzinga
Inari Medical Catapults 30% On Rumored Stryker Takeover
↗
January 06, 2025
Inari is best-known for its series of catheter-like devices that remove blood clots.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
↗
December 18, 2024
Via
Benzinga
Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst
↗
December 17, 2024
Oppenheimer predicts growth for Penumbra Inc in MT market. Analyst initiates coverage with Outperform rating and $275 target price.
Via
Benzinga
This Elastic Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
↗
December 17, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
